BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18158572)

  • 21. Ultrasonographic endometrial monitoring during continuous-sequential hormonal replacement therapy regimen in postmenopausal women.
    Affinito P; Palomba S; Sammartino A; Bonifacio M; Nappi C
    Maturitas; 2001 Sep; 39(3):239-44. PubMed ID: 11574183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endometrial sonographic and histologic findings in women with and without hormonal replacement therapy suffering from postmenopausal bleeding.
    Granberg S; Ylöstalo P; Wikland M; Karlsson B
    Maturitas; 1997 May; 27(1):35-40. PubMed ID: 9158075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disturbances of endometrial bleeding with hormone replacement therapy.
    Thomas AM; Hickey M; Fraser IS
    Hum Reprod; 2000 Aug; 15 Suppl 3():7-17. PubMed ID: 11041216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of outpatient hysteroscopy in diagnosing endometrial pathology in postmenopausal women with and without hormone replacement therapy.
    Elliott J; Connor ME; Lashen H
    Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1112-9. PubMed ID: 14616256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HRT in post-menopausal women: endometrial histology and bleeding patterns].
    Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM
    Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens.
    Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA
    J Am Geriatr Soc; 1979 Sep; 27(9):389-94. PubMed ID: 469150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histological Pattern Of Endometrial Samples In Postmenopausal Women With Abnormal Uterine Bleeding.
    Deeba F; Shaista ; Khan B
    J Ayub Med Coll Abbottabad; 2016; 28(4):721-724. PubMed ID: 28586596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal replacement therapy and evaluation of intrauterine pathology in postmenopausal women: a ten-year study.
    Mossa B; Imperato F; Marziani R; Perniola F; Melluso J; Perniola G; Napolitano C
    Eur J Gynaecol Oncol; 2003; 24(6):507-12. PubMed ID: 14658591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
    Ivanov S
    Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is bleeding a predictor of endometrial hyperplasia in postmenopausal women receiving hormone replacement therapy? Menopause Study Group (United States, Italy, Netherlands, Switzerland, Belgium, Germany, and Finland.
    Pickar JH; Archer DF
    Am J Obstet Gynecol; 1997 Nov; 177(5):1178-83. PubMed ID: 9396916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy? UK Continuous Combined HRT Study Investigators.
    Sturdee DW; Barlow DH; Ulrich LG; Wells M; Gydesen H; Campbell M; O'Brien K; Vessey M
    Lancet; 1994 Oct; 344(8928):979-82. PubMed ID: 7934429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometrial safety and tolerability of AERODIOL(R) (intranasal estradiol) for 1 year.
    Gompel A; Bergeron C; Jondet M; Dhont M; Van der Mooren MJ; Toth KS; Panay N; Von Holst T
    Maturitas; 2000 Oct; 36(3):209-15. PubMed ID: 11063903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial ablation for postmenopausal uterine bleeding induced by hormone replacement therapy.
    Phillips DR
    J Am Assoc Gynecol Laparosc; 1995 Aug; 2(4):389-93. PubMed ID: 9050590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of postmenopausal bleeding to prevent endometrial cancer.
    Gambrell RD; Castaneda TA; Ricci CA
    Maturitas; 1978 Sep; 1(2):99-106. PubMed ID: 755962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
    Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
    Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hysteroscopy in women with abnormal uterine bleeding on hormone replacement therapy: a comparison with postmenopausal bleeding.
    Nagele F; O'Connor H; Baskett TF; Davies A; Mohammed H; Magos AL
    Fertil Steril; 1996 Jun; 65(6):1145-50. PubMed ID: 8641488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer.
    Gull B; Karlsson B; Milsom I; Granberg S
    Am J Obstet Gynecol; 2003 Feb; 188(2):401-8. PubMed ID: 12592247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.